收藏切换
Retrospective analysis of doxycycline in the treatment of lobular pneumonia infected by drug-resistant Mycoplasma pneumoniae in children
收藏切换
Yu ZHANG1, Yuhan GU1, Zhuo WANG1, Zhixin ZHENG1, Ping ZHU2, *
World Clinical Drug | 2024, 45(10) : 1072 - 1077
Less
收藏切换
World Clinical Drug | 2024, 45(10): 1072-1077
• Article •
Retrospective analysis of doxycycline in the treatment of lobular pneumonia infected by drug-resistant Mycoplasma pneumoniae in children
Full
Yu ZHANG1, Yuhan GU1, Zhuo WANG1, Zhixin ZHENG1, Ping ZHU2, *
Affiliations
  • 1.Department of Clinical Pharmacy, Nanyang Central Hospital, Nanyang 473000, Henan Province, China
  • 2.Neonatal Intensive Care Unit, Nanyang Central Hospital, Nanyang 473000, Henan Province, China
Published: 2024-10-10 doi: 10.13683/j.wph.2024.10.012
Outline
收藏切换
Objective

To investigate the safety and efficacy of doxycycline in the treatment of lobular pneumonia infected by drug-resistant Mycoplasma pneumoniae (MP) in children.

Methods

Children with lobular pneumonia infected by drug-resistant MP admitted to our hospital from July 2023 to April 2024 were selected as the study objects, and their clinical manifestations, etiology detection, laboratory and imaging examination, clinical efficacy and safety were collected and analyzed during hospitalization.

Results

Among the 65 patients, there were 34 males and 31 females, of which 28 were ≥8 years old and 37 were <8 years old, with an average age of (7.73±2.41) years. The most common clinical manifestations were cough (65 cases, 100.0%) and fever (64 cases, 98.46%). The right lung was mainly involved in pneumonia (33 cases, 50.77%). The average course of treatment with doxycycline was (7.43±2.95) days, with a dosage of 2 mg/kg every 12 hours. After treatment, the average body temperature of 50 cases (76.92%) dropped to normal within (1.76±1.20) days, 55 cases (84.62%) showed significantly improvement in cough symptoms within (3.58±1.89) days, and 54 cases (83.08%) showed significant absorption in lung imaging, with an average time of (9.00±0.63) days. There was 1 case of rash and 1 case of pain during medication period. After discharge, follow-up was conducted until 3 months after medication, and no drug-related adverse reactions occurred.

Conclusion

Doxycycline is safe in the treatment of lobular pneumonia infected by drug-resistant MP in children with proper dose and short course of treatment, and can be appropriately selected in clinical pratice.

doxycycline  /  children  /  macrolide resistant Mycoplasma pneumoniae  /  lobular pneumonia  /  security
张宇, 顾愚汉, 王卓, 郑芝欣, 朱萍. 多西环素治疗儿童耐药肺炎支原体感染性大叶性肺炎回顾性分析. 世界临床药物, 2024 , 45 (10) : 1072 -1077 . DOI: 10.13683/j.wph.2024.10.012
Yu ZHANG, Yuhan GU, Zhuo WANG, Zhixin ZHENG, Ping ZHU. Retrospective analysis of doxycycline in the treatment of lobular pneumonia infected by drug-resistant Mycoplasma pneumoniae in children[J]. World Clinical Drug, 2024 , 45 (10) : 1072 -1077 . DOI: 10.13683/j.wph.2024.10.012
Year 2024 volume 45 Issue 10
18
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.10.012
  • Receive Date:2024-05-20
  • Online Date:2026-11-17
  • Published:2024-10-10
Article Data
Affiliations
History
  • Received:2024-05-20
  • Revised:2024-09-12
Funding
Affiliations
    1.Department of Clinical Pharmacy, Nanyang Central Hospital, Nanyang 473000, Henan Province, China
    2.Neonatal Intensive Care Unit, Nanyang Central Hospital, Nanyang 473000, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.10.012
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT